Yellow fever infection
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: > 18 years having been administered a yellow fever vaccination
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure is the proportion of volunteers who have 0.7 log10 plaque reduction, as challenge experiments have shown this to correlate with protection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Another outcome measure is the proportion of volunteers who have YF-17D-specific memory, as shown by the presence of YF-17D-specific cytokine producing CD8+ and CD4+ T cells. | — |
Countries
Netherlands
Outcome results
None listed